ArticleSexually transmitted diseases2026
High Prevalence of and Low Testing for Sexually Transmitted Infections Among Transgender Women in Cali, Colombia.
Article in Sexually transmitted diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundTransgender women (TGW) are disproportionately impacted by sexually transmitted infections (STIs). To date, few studies have been done on STIs in TGW from Latin America. We sought to estimate the prevalence of human immunodeficiency virus, human papillomavirus (HPV), hepatitis B and C, syphilis, gonorrhea, and chlamydia among TGW in Cali, Colombia.
methodsWe conducted a cross-sectional study using respondent-driven sampling between May and November 2023. Eight TGW seeds initiated recruitment chains. Eligible participants completed a survey, underwent a physical examination, and were tested for STIs, including pooled swabs for HPV, chlamydia, and gonorrhea. Network size-adjusted prevalence estimates with their corresponding 95% confidence intervals (95% CI) were calculated using respondent-driven sampling-II weighting.
resultsA total of 169 TGW were enrolled. The median age was 39 years, 69% reported engaging in transactional sex in the past year, and 68% reported condomless sex during their last encounter. Only 50% had been tested for any STIs in the past year. Adjusted prevalence estimates were 45.8% (95% CI: 31.9-59.6) for human immunodeficiency virus, 41.3% (95% CI: 27.0-55.7) for high-risk HPV, 16.9% (95% CI: 3.7-30.1) for gonorrhea, 15.5% (95% CI: 3.9-27.1) for chlamydia, 14.8% (95% CI: 6.9-22.6) for presumptive active syphilis, 4.6% (95% CI: 0-10.1) for hepatitis B, and 1.7% (95% CI: 0-3.4) for hepatitis C. Approximately 40% had multiple infections. Most cases of chlamydia and gonorrhea were asymptomatic.
conclusionsSTIs are highly prevalent among TGW in Cali. These findings highlight the urgent need for expanded diagnostic capacity and community-centered interventions to improve sexual health among TGW.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.